FOSFOMYCIN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C3H7O4P
Molecular Weight	138.059
Optical Activity	( - )
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of FOSFOMYCIN

Structure Search

SMILES

C[C@@H]1O[C@@H]1P(O)(O)=O

InChI

InChIKey=YMDXZJFXQJVXBF-STHAYSLISA-N

InChI=1S/C3H7O4P/c1-2-3(7-2)8(4,5)6/h2-3H,1H3,(H2,4,5,6)/t2-,3+/m0/s1

HIDE SMILES / InChI

Molecular Formula	C3H7O4P
Molecular Weight	138.059
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:26:30 UTC 2023` Edited by `admin` on `Fri Dec 15 16:26:30 UTC 2023`
Record UNII	2N81MY12TE
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FOSFOMYCIN

Official Name

English

FOSFOMYCIN [JAN]

Common Name

English

PHOSPHONIC ACID, (3-METHYLOXIRANYL)-, (2R-CIS)-

Common Name

English

fosfomycin [INN]

Common Name

English

FOSFOMYCIN [USAN]

Common Name

English

J01XX01

Code

English

FOSFOMYCIN [MART.]

Common Name

English

ZTI-01

Code

English

(-)-(1R,2S)-(1,2-EPOXYPROPYL)PHOSPHONIC ACID

Systematic Name

English

Fosfomycin [WHO-DD]

Common Name

English

FOSFOMYCIN [VANDF]

Common Name

English

FOSFOMYCIN [MI]

Common Name

English

Classification Tree Code System Code

WHO-ATC

J01XX01

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

NCI_THESAURUS

C255

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

WHO-VATC

QJ01XX01

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

LIVERTOX

NBK547912

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

FDA ORPHAN DRUG

271908

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

Code System Code Type Description

ChEMBL

CHEMBL1757

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

CAS

23155-02-4

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

DRUG BANK

DB00828

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

MERCK INDEX

m5551

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

Merck Index

INN

3014

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

CHEBI

62247

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

CHEBI

62419

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

DRUG CENTRAL

1243

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

RXCUI

4550

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

RxNorm

CHEBI

28915

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

DAILYMED

2N81MY12TE

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

MESH

D005578

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

FDA UNII

2N81MY12TE

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

NCI_THESAURUS

C61772

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

WIKIPEDIA

FOSFOMYCIN

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

LACTMED

Fosfomycin

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

ECHA (EC/EINECS)

245-463-1

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

EVMPD

SUB07797MIG

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

EPA CompTox

DTXSID4048480

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

PUBCHEM

446987

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

SMS_ID

100000086575

Created by admin on Fri Dec 15 16:26:30 UTC 2023 , Edited by admin on Fri Dec 15 16:26:30 UTC 2023

PRIMARY

Related Record Type Details


					97MMO19FNO

FOSFOMYCIN SODIUM

SALT/SOLVATE -> PARENT


					0F86SNQ5NQ

FOSFOMYCIN MONOSODIUM

SALT/SOLVATE -> PARENT


					SS0BBT2OLA

FOSFOMYCIN MAGNESIUM

SALT/SOLVATE -> PARENT

Amount:


					28ICO0PV2E

UDP-N-ACETYLGLUCOSAMINE ENOLPYRUVYL TRANSFERASE (GRAM NEGATIVE BACTERIA)

TARGET -> INHIBITOR


					50V5RBU89I

FOSFOMYCIN (R)-1-PHENETHYLAMINE

SALT/SOLVATE -> PARENT


					7FXW6U30GY

FOSFOMYCIN TROMETHAMINE

SALT/SOLVATE -> PARENT


					UP65AB4GDC

UDP-N-ACETYLGLUCOSAMINE ENOLPYRUVYL TRANSFERASE (GRAM POSITIVE BACTERIA)

TARGET -> INHIBITOR


					76EIK6888N

FOSFOMYCIN CALCIUM

SALT/SOLVATE -> PARENT

Amount:


					T330QG2NYS

FOSFOMYCIN CALCIUM MONOHYDRATE

SALT/SOLVATE -> PARENT

Amount:


					G730UKG7UL

FOSFOMYCIN ETHYLENEDIAMINE MONOBASIC

SALT/SOLVATE -> PARENT

Amount:

Related Record Type Details


					2N81MY12TE

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Cmax	PHARMACOKINETIC				ROUTE OF ADMINISTRATION: ORAL FOOD EFFECT: WITH A HIGH-FAT MEAL TIME: WITHIN 4 HOURS DOSE: 3 GRAMS

Volume of Distribution	PHARMACOKINETIC

ORAL BIOAVAILABILITY	PHARMACOKINETIC				FOOD EFFECT: FED

MIC	BIOLOGICAL

MIC	BIOLOGICAL

MIC	BIOLOGICAL

Volume of Distribution	PHARMACOKINETIC

ORAL BIOAVAILABILITY	PHARMACOKINETIC				FOOD EFFECT: FASTING

Cmax	PHARMACOKINETIC				DOSE: 3 GRAMS ROUTE OF ADMINISTRATION: ORAL FOOD EFECT: FASTING TIME: WITHIN 2 HOURS

Biological Half-life	PHARMACOKINETIC